Vertex, Seattle Genetics, Alpine withdraw from investor conference as biotechs brace for coronavirus
In the first glimpse of how the coronavirus’s growing US spread could disrupt operations at American biotechs, a pair of major companies withdrew today from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.